Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study.

Sawada R, Yamada T, Goto Y, Negi Y, Nakao A, Yoshimura A, Furuya N, Oba T, Hibino M, Nakatani H, Taniguchi H, Ohtsubo A, Watanabe S, Yamada T, Chihara Y, Kijima T, Takayama K

Open source

DOI: 10.21037/tlcr-2024-1180
Published: 2025 Jun 30
Container: Translational lung cancer research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-2024-1180,
  title = {Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study.},
  author = {Sawada R and Yamada T and Goto Y and Negi Y and Nakao A and Yoshimura A and Furuya N and Oba T and Hibino M and Nakatani H and Taniguchi H and Ohtsubo A and Watanabe S and Yamada T and Chihara Y and Kijima T and Takayama K},
  year = {2025},
  journal = {Translational lung cancer research},
  doi = {10.21037/tlcr-2024-1180},
  url = {https://doi.org/10.21037/tlcr-2024-1180}
}

RIS

TY  - JOUR
TI  - Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study.
AU  - Sawada R
AU  - Yamada T
AU  - Goto Y
AU  - Negi Y
AU  - Nakao A
AU  - Yoshimura A
AU  - Furuya N
AU  - Oba T
AU  - Hibino M
AU  - Nakatani H
AU  - Taniguchi H
AU  - Ohtsubo A
AU  - Watanabe S
AU  - Yamada T
AU  - Chihara Y
AU  - Kijima T
AU  - Takayama K
PY  - 2025
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-2024-1180
UR  - https://doi.org/10.21037/tlcr-2024-1180
ER  -

APA

R, S., T, Y., Y, G., Y, N., A, N., A, Y., N, F., T, O., M, H., H, N., H, T., A, O., S, W., T, Y., Y, C., T, K., & K, T. (2025). Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2024-1180

Source records

pubmed · retrieved 2026-09-26T22:42:44.427Z